Nonanesthesiologist-administered propofol sedation: from the exception to standard practice. Sedation and monitoring trends over 20 years

The practice of sedation, including monitoring practice for digestive endoscopy, continues to evolve throughout the world. In many countries, including Switzerland, there is a trend towards increased utilization of sedation during both routine and advanced endoscopic procedures. Sedation improves patient satisfaction with endoscopy and also improves the quality of the examination. In addition, a trend can be observed towards an increasing use of propofol as the preferred sedative drug. Here we review the latest published data from surveys describing sedation and monitoring practice in different countries and compare them with our own data from successive nationwide surveys among Swiss gastroenterologists over a period of 20 years. This development between these socioeconomically very similar Western industrialized countries, however, shows some unique and surprising differences. In Germany and Switzerland, propofol use has become increasingly widespread, in Switzerland even to the extent that during the last few years propofol has overtaken benzodiazepine sedation, with an absolute majority of Swiss gastroenterologists using it without the assistance of an anesthesiologist. In addition, the change in Switzerland reflects a successful generalization of nonanesthesiologist-administered propofol (NAAP) sedation from the hospital setting to private practice.

• References

• 1 Hirschowitz BI. A personal history of the fiberscope. Gastroenterology 1979; 76: 864-869
• 2 Firth JD. An anesthetic technique for oral endoscopy. Anesth Analg 1960; 39: 175-179
• 3 Ticktin HE, Trujillo NP. Evaluation of diazepam for pre-endoscopy medication. Am J Dig Dis 1965; 10: 979-984
• 4 Williams C, Muto T. Examination of the whole colon with the fibreoptic colonoscope. Br Med J 1972; 3: 278-281
• 5 Ludlam R, Bennett JR. Comparison of diazepam and morphine as premedication for gastrointestinal endoscopy. Lancet 1971; 2: 1397-1399
• 6 Berry LH. How important is endoscopic premedication. Gastrointest Endosc 1969; 15: 170-171
• 7 Cole SG, Brozinsky S, Isenberg JI. Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives. Gastrointest Endosc 1983; 29: 219-222
• 8 Arrowsmith JB, Gerstman BB, Fleischer DE et al. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc 1991; 37: 421-427
• 9 Kirkegaard L, Knudsen L, Jensen S et al. Benzodiazepine antagonist Ro 15–1788. Antagonism of diazepam sedation in outpatients undergoing gastroscopy. Anaesthesia 1986; 41: 1184-1188
• 10 Keeffe EB, O’Connor KW. 1989 A/S/G/E survey of endoscopic sedation and monitoring practices. Gastrointest Endosc 1990; 36: 13-18
• 11 Ladas SD, Aabakken L, Rey JF et al. Use of sedation for routine diagnostic upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society Members. Digestion 2006; 74: 69-77
• 12 Paspatis GA, Manolaraki MM, Tribonias G et al. Endoscopic sedation in Greece: results from a nationwide survey for the Hellenic Foundation of gastroenterology and nutrition. Dig Liver Dis 2009; 41: 807-811
• 13 McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc 2008; 67: 910-923
• 14 Radaelli F, Meucci G, Sgroi G et al. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008; 103: 1122-1130
• 15 Ladas SD, Satake Y, Mostafa I et al. Sedation practices for gastrointestinal endoscopy in Europe, North America, Asia, Africa and Australia. Digestion 2010; 82: 74-76
• 16 Heuss LT, Peter S. Propofol use by gastroenterologists-the European experience. Gastrointest Endosc Clin N Am 2008; 18: 727-738, ix
• 17 Riphaus A, Rabofski M, Wehrmann T. Endoscopic sedation and monitoring practice in Germany: results from the first nationwide survey. Z Gastroenterol 2010; 48: 392-397
• 18 Cohen LB, Wecsler JS, Gaetano JN et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 2006; 101: 967-974
• 19 Baudet JS, Borque P, Borja E et al. Use of sedation in gastrointestinal endoscopy: a nationwide survey in Spain. Eur J Gastroenterol Hepatol 2009; 21: 882-888
• 20 Fanti L, Agostoni M, Gemma M et al. Sedation and monitoring for gastrointestinal endoscopy: A nationwide web survey in Italy. Dig Liver Dis 2011; 43: 726-730
• 21 Porostocky P, Chiba N, Colacino P et al. A survey of sedation practices for colonoscopy in Canada. Can J Gastroenterol 2011; 25: 255-260
• 22 Ristikankare MK, Julkunen RJ. Premedication for gastrointestinal endoscopy is a rare practice in Finland: a nationwide survey. Gastrointest Endosc 1998; 47: 204-207
• 23 Bell GD. Premedication, preparation, and surveillance. Endoscopy 2000; 32: 92-100
• 24 Benson AA, Cohen LB, Waye JD et al. Endoscopic sedation in developing and developed countries. Gut Liver 2008; 2: 105-112
• 25 Aisenberg J, Brill JV, Ladabaum U et al. Sedation for gastrointestinal endoscopy: new practices, new economics. Am J Gastroenterol 2005; 100: 996-1000
• 26 Rex DK, Heuss LT, Walker JA et al. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology 2005; 129: 1384-1391
• 27 Rex DK. The science and politics of propofol. Am J Gastroenterol 2004; 99: 2080-2083
• 28 Rex DK, Overley C, Kinser K et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol 2002; 97: 1159-1163
• 29 Vargo JJ, Zuccaro Jr G et al. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology 2002; 123: 8-16
• 30 Kumar P. Science and politics of propofol. Am J Gastroenterol 2005; 100: 1204-1205
• 31 Dumonceau JM, Riphaus A, Aparicio JR et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 2010; 42: 960-974
• 32 Heuss LT, Froehlich F, Beglinger C. Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland. Endoscopy 2005; 37: 161-166
• 33 Froehlich F, Gonvers JJ, Fried M. Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland. Endoscopy 1994; 26: 231-234
• 34 Froehlich F, Burnand B, Pache I et al. Overuse of upper gastrointestinal endoscopy in a country with open-access endoscopy: a prospective study in primary care. Gastrointest Endosc 1997; 45: 13-19
• 35 Quine MA, Bell GD, McCloy RF et al. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut 1995; 36: 462-467
• 36 Froehlich F, Gonvers JJ, Vader JP et al. Appropriateness of gastrointestinal endoscopy: risk of complications. Endoscopy 1999; 31: 684-686
• 37 Rex DK, Deenadayalu VP, Eid E et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology 2009; 137: 1229-1237 quiz 1518-1229
• 38 Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: a risk factor analysis. Scand J Gastroenterol 2008; 43: 368-374
• 39 Dumonceau JM, Riphaus A, Aparicio JR et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 42: 960-974
• 40 Cohen LB, Dubovsky AN, Aisenberg J et al. Propofol for endoscopic sedation: A protocol for safe and effective administration by the gastroenterologist. Gastrointest Endosc 2003; 58: 725-732
• 41 Kulling D, Orlandi M, Inauen W. Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary?. Gastrointest Endosc 2007; 66: 443-449
• 42 Yusoff IF, Raymond G, Sahai AV. Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. Gastrointest Endosc 2004; 60: 356-360
• 43 Peter S, Wunderlich P, Beglinger C et al. Is nurse administered propofol sedation (NAPS) safe for endoscopies in a gastroenterologist ambulatory practice? [abstract]. Gastroenterology 2007; 132: A129
• 44 Froehlich F, Milliet N. Propofol sedation during endoscopic procedures in private practice: the case for capnography to make 1-nurse endoscopy acceptable. Gastrointest Endosc 2008; 67: 1008
• 45 Heuss LT, Schnieper P, Drewe J et al. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc 2003; 57: 664-671
• 46 Oei-Lim VL, Kalkman CJ, Bartelsman JF et al. Cardiovascular responses, arterial oxygen saturation and plasma catecholamine concentration during upper gastrointestinal endoscopy using conscious sedation with midazolam or propofol. Eur J Anaesthesiol 1998; 15: 535-543
• 47 Heuss LT, Schnieper P, Drewe J et al. Conscious sedation with propofol in elderly patients: a prospective evaluation. Aliment Pharmacol Ther 2003; 17: 1493-1501
• 48 Kulling D, Rothenbuhler R, Inauen W. Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy. Endoscopy 2003; 35: 679-682